Table 2. Recent proposal for medical guidelines in RSTS patients.
Diagnosis | 6 M | 12 M | 18 M | 24 M | 30 M | >36 M (yearly) | Adolescent age | |
---|---|---|---|---|---|---|---|---|
Brain and medullary NMRa | X | X | ||||||
Neuropsychiatric evaluation | X | X | ||||||
Dermatologic evaluationa | X | X | ||||||
Genetic counseling | X | X | ||||||
Cardiologic evaluationa | X | X | ||||||
Renal US scana | X | X | ||||||
Pressure measurement | X | X | ||||||
Endocrinological evaluationa | X | X | X | |||||
Ophthalmologic evaluation | X | X | X | X | X | X | ||
Odontoiatric evaluation | X | X | X | X | X | X | ||
Orthopedic evaluation | X | X | X | X | X | X | X | X |
Audiologic evaluation | X | X | X | X | X | X | X | X |
Abbreviations: M, months; NMR, nuclear magnetic resonance; RSTS, Rubinstein–Taybi syndrome; US, ultrasonography.
Note: Medical evaluations and examinations are in order of number and earliness in the first 3 years of age.
Follow-up if necessary.